Natera
NTRA
#597
Rank
A$59.89 B
Marketcap
A$413.05
Share price
-5.70%
Change (1 day)
22.01%
Change (1 year)

Earnings for Natera (NTRA)

Earnings in 2026 (TTM): -A$0.38 Billion

According to Natera's latest financial reports the company's current earnings are A$2.70 Billion. In 2025 the company made an earning of -A$0.41 Billion a decrease over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Natera from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.38 Billion-8.2%
2025 -A$0.41 Billion41.3%
2024 -A$0.29 Billion-56.34%
2023 -A$0.66 Billion-20.54%
2022 -A$0.83 Billion16.07%
2021 -A$0.72 Billion105.14%
2020 -A$0.35 Billion86.97%
2019 -A$0.19 Billion-3.92%
2018 -A$0.2 Billion-5.63%
2017 -A$0.21 Billion41.66%
2016 -A$0.15 Billion36.07%
2015 -A$0.11 Billion1264.03%
2014 -A$7.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vertex Pharmaceuticals
VRTX
A$6.89 B-1,904.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Prothena
PRTA
-A$90.45 Million-76.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Paratek Pharmaceuticals
PRTK
-A$66.04 Million-82.70%๐Ÿ‡บ๐Ÿ‡ธ USA